SMURF-Therapeutics, Inc. is developing small molecule therapeutics to activate or block Smurf2 for cancer, anemia and wound healing. The company was founded by Wafik El-Deiry, MD, PhD, FACP in 2021 to develop small molecule compounds targeting hypoxia responses based on numerous academic research papers and reviews published over 3 decades.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Providence , Rhode Island , Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://smurftherapeutics.com/
- Keywords
- cancer, anemia, wound healing, oncology, hematology, biotechnology, pharmaceutical, healthcare, medicine, hypoxia, protein degradation, micro RNA, small molecule, clinical trials.
- HQ
- Providence , Rhode Island
Smurf-Therapeutics, Inc. Questions
Smurf-Therapeutics, Inc.'s website is https://smurftherapeutics.com/
Smurf-Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/smurf-therapeutics
Smurf-Therapeutics, Inc. has
5 employees.
View email and phone details for 5
employees at Smurf-Therapeutics, Inc..
Smurf-Therapeutics, Inc.'s industry is
Pharmaceutical Manufacturing
Smurf-Therapeutics, Inc.'s top competitors are
Tosk, Inc.,
National Academy Of Inventors,
Pharmaphorum,
Dph Biologicals,
Genecentric,
Novus Biologicals, A Bio-Techne Brand,
Arbor (Acquired By Liveramp),
Goswift,
P53-Therapeutics, Inc.,
Kapadi.
Smurf-Therapeutics, Inc.'s categories are Pharmaceutical Manufacturing
Smurf-Therapeutics, Inc.'s founding year is 2021
